Prediction of late distant recurrence (DR) using the Prosigna (PAM50) test in a Danish Breast Cancer Cooperative Group (DBCG) cohort of postmenopausal women diagnosed with hormone receptor-positive (HR+) early breast cancer (EBC) allocated to 5yr of endocrine therapy (ET).

Anne-Vibeke Lænkholm,Torben Kibøll,Carl Schaper,Jens Ole Eriksen,Birgitte Bruun Rasmussen,Taryn Haffner,Bent Ejlertsen,Sean Ferree,Maj-Britt Jensen,Ann S Knoop

doi:10.1200/jco.2015.33.15_suppl.544

Prediction of late distant recurrence (DR) using the Prosigna (PAM50) test in a Danish Breast Cancer Cooperative Group (DBCG) cohort of postmenopausal women diagnosed with hormone receptor-positive (HR+) early breast cancer (EBC) allocated to 5yr of endocrine therapy (ET).

Anne-Vibeke Lænkholm, Torben Kibøll + Show 8 more

https://doi.org/10.1200/jco.2015.33.15_suppl.544

Copy DOI

Journal: Journal of Clinical Oncology	Publication Date: May 20, 2015
Citations: 3

Affiliation: Herlev Hospital, Copenhagen University Hospital

#Prediction Of Late Distant Recurrence #Danish Breast Cancer Cooperative Group + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

544 Background: Accurate assessment of the risk of late DR (5-10 yr after surgery) may be used to tailor the duration of ET for patients with HR+ EBC. The Prosigna (PAM50) risk of recurrence (ROR) ...

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Journal of Clinical Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.